Remove 2023 Remove BioTech Remove Healthcare Innovation Remove Telemedicine
article thumbnail

SpringTide Ventures Announces the Close of $65 Million Fund II

Digital Health Global

Pathology Watch : An end-to-end dermatopathology software platform, including AI interpretation; acquired by Sonic Healthcare in January 2024 for $150 million. Debut Biotech : A leading cell-free biomanufacturing company that launched its own skin care product line in 2023 and raised a $20 million Series B led by L’Oreal.